Abata Therapeutics
Amount undisclosed
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Abata Therapeutics is currently valued at N/A as of August 15, 2024. The company has raised a total of $110.3M in funding.
Investment Perspective
Abata Therapeutics's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Abata Therapeutics Worth in 2025?
As of 2025, Abata Therapeutics is valued at N/A, based on the company's Early Stage VC funding round in August 15, 2024. This valuation positions Abata Therapeutics as one of the leading private companies in the sector.
Abata Therapeutics Valuation History
Abata Therapeutics's funding history demonstrates steady growth and investor confidence.
How Abata Therapeutics Valuation is Determined
Private company valuations like Abata Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Abata Therapeutics Valuation FAQs
Is Abata Therapeutics profitable?
Abata Therapeutics has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Abata Therapeutics's valuation compare to competitors?
Abata Therapeutics is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Abata Therapeutics IPO?
Abata Therapeutics has not announced plans for an initial public offering. Until an IPO, investors can access Abata Therapeutics shares through secondary market platforms.